Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

Breast cancer runs in my family so I’ve always been vigilant about self-checking. As soon as I found a lump, in 2021, I went ...

In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, new research finds.

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant ...

Researchers have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients. The findings show two distinct patterns of B cell ...

A team of MUSC Hollings Cancer Center researchers has discovered one way in which triple-negative breast cancer (TNBC) cells become resistant to immunotherapy and have tested a two-pronged treatment ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative ...

Offering universal genetic testing to newly diagnosed breast cancer patients may identify germline pathogenic variants, which ...

Hollings Cancer Center researchers have identified one reason why triple-negative breast cancer becomes resistant to ...